- Home
- ECOR vs NSPR Comparison
ECOR vs NSPR Comparison
Compare ECOR & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- NSPR
- Stock Information
- Founded
- ECOR 2005
- NSPR 2005
- Country
- ECOR United States
- NSPR Israel
- Employees
- ECOR N/A
- NSPR N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NSPR Medical/Dental Instruments
- Sector
- ECOR Health Care
- NSPR Health Care
- Exchange
- ECOR Nasdaq
- NSPR Nasdaq
- Market Cap
- ECOR 65.0M
- NSPR 63.0M
- IPO Year
- ECOR 2018
- NSPR N/A
- Fundamental
- Price
- ECOR $16.49
- NSPR $2.91
- Analyst Decision
- ECOR Strong Buy
- NSPR Strong Buy
- Analyst Count
- ECOR 1
- NSPR 2
- Target Price
- ECOR $15.00
- NSPR $4.75
- AVG Volume (30 Days)
- ECOR 97.7K
- NSPR 78.6K
- Earning Date
- ECOR 11-13-2024
- NSPR 11-12-2024
- Dividend Yield
- ECOR N/A
- NSPR N/A
- EPS Growth
- ECOR N/A
- NSPR N/A
- EPS
- ECOR N/A
- NSPR N/A
- Revenue
- ECOR $23,327,000.00
- NSPR $6,821,000.00
- Revenue This Year
- ECOR $61.40
- NSPR $13.31
- Revenue Next Year
- ECOR $38.43
- NSPR $52.91
- P/E Ratio
- ECOR N/A
- NSPR N/A
- Revenue Growth
- ECOR 74.10
- NSPR 24.70
- 52 Week Low
- ECOR $5.25
- NSPR $1.81
- 52 Week High
- ECOR $15.25
- NSPR $3.42
- Technical
- Relative Strength Index (RSI)
- ECOR 69.93
- NSPR 52.69
- Support Level
- ECOR $13.22
- NSPR $2.78
- Resistance Level
- ECOR $14.87
- NSPR $3.15
- Average True Range (ATR)
- ECOR 1.34
- NSPR 0.22
- MACD
- ECOR 0.30
- NSPR -0.03
- Stochastic Oscillator
- ECOR 87.04
- NSPR 47.58
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.